標(biāo)題: Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn [打印本頁] 作者: 強(qiáng)烈興趣 時(shí)間: 2025-3-21 16:49
書目名稱Renal Cancer影響因子(影響力)
書目名稱Renal Cancer影響因子(影響力)學(xué)科排名
書目名稱Renal Cancer網(wǎng)絡(luò)公開度
書目名稱Renal Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Renal Cancer被引頻次
書目名稱Renal Cancer被引頻次學(xué)科排名
書目名稱Renal Cancer年度引用
書目名稱Renal Cancer年度引用學(xué)科排名
書目名稱Renal Cancer讀者反饋
書目名稱Renal Cancer讀者反饋學(xué)科排名
作者: 亂砍 時(shí)間: 2025-3-21 22:16 作者: 植物群 時(shí)間: 2025-3-22 03:15 作者: 漫步 時(shí)間: 2025-3-22 07:39 作者: Hot-Flash 時(shí)間: 2025-3-22 12:14
978-3-030-84758-6Springer Nature Switzerland AG 2022作者: ADJ 時(shí)間: 2025-3-22 14:16
Metastatic Tumours: Cytoreductive Nephrectomy,tatic renal cell carcinoma. The evidence surrounding this controversial treatment is reviewed and other indications for nephrectomy are discussed. We discuss the complex issues surrounding patient selection and how this may be improved in the future to choose the appropriate case for CRN.作者: 嚙齒動(dòng)物 時(shí)間: 2025-3-22 18:00 作者: 記憶 時(shí)間: 2025-3-22 22:24 作者: sinoatrial-node 時(shí)間: 2025-3-23 05:25 作者: 孵卵器 時(shí)間: 2025-3-23 05:47
Scott T. C. Shepherd,Samra Turajlicxis and time on the horizontal axis. For Group ., the survival rate (or 1 ? the mortality rate) declines steadily over the 5 years of observation. For Group ., however, the decline in the survival rate is rapid during the first year and then levels off. Obviously, the survival experience of the two 作者: 新陳代謝 時(shí)間: 2025-3-23 11:44
Vincenzo Ficarra,Simona Caloggero,Marta Rossanese,Silvio Mazziotti,Giuseppe Mucciardi,Giuseppe Cicerxis and time on the horizontal axis. For Group ., the survival rate (or 1 ? the mortality rate) declines steadily over the 5 years of observation. For Group ., however, the decline in the survival rate is rapid during the first year and then levels off. Obviously, the survival experience of the two 作者: conscribe 時(shí)間: 2025-3-23 15:54
Pieter J. le Rouxation, and, ultimately, burn-out. As such, droplets can be considered the building block for providing fuel vapor in combustion systems. Understanding of single-droplet evaporation and combustion processes therefore provides important guidance in design of practical burners. Topics covered in this c作者: Accessible 時(shí)間: 2025-3-23 21:55
Wing Kin Liu,Mehran Afshar,Lisa Pickeringation, and, ultimately, burn-out. As such, droplets can be considered the building block for providing fuel vapor in combustion systems. Understanding of single-droplet evaporation and combustion processes therefore provides important guidance in design of practical burners. Topics covered in this c作者: FLOUR 時(shí)間: 2025-3-24 00:57 作者: CHAFE 時(shí)間: 2025-3-24 05:23
P. Brousil,David Manson-Bahr,David Nicolal and Local Effects of Disease of the Suprarenal Capsules -were seminal. However, the stimulus of this early research did not bring imme- diate widespread further investigations. Upon the discovery of secretin in 1902, Bayliss and Starling considered the term "internal secretion" to be clumsy, and 作者: NATAL 時(shí)間: 2025-3-24 10:10
Epidemiology and Screening in RCC, resume research on this topic, both from the research community and patient groups. The optimal screening modality is yet to be elucidated: ultrasound or low-dose CT are the most likely options. Blood or urinary biomarkers remain an attractive avenue, however none have been validated for use in cli作者: 浪費(fèi)物質(zhì) 時(shí)間: 2025-3-24 13:35
Hereditary Renal Cancer Predisposition Syndromes,ogg–Dube syndrome, hereditary RCC and leiomyomatosis and hereditary papillary RCC) although there is limited guidance for more recently described clinical entities..The management approach to renal tumours varies between syndromes. Active surveillance of renal masses is performed in syndromes where 作者: BINGE 時(shí)間: 2025-3-24 17:14 作者: 起皺紋 時(shí)間: 2025-3-24 20:49
Biomarkers, Early Detection and Biomarker Based Treatment of Renal Cancer,s in biomarker evaluation and imaging modalities has ushered a renewed interest in biomarker and other early detection strategies. Herein, this chapter will outline the current existing and future perspectives on biomarkers and early detection strategies. Some of the biomarkers have helped individua作者: 變白 時(shí)間: 2025-3-24 23:30
Active Surveillance in Renal Cancer,ron sparing approaches to manage the SRM. The preferred surgical option and current standard of care is a partial nephrectomy which has been shown to provide excellent oncologic outcomes with preservation of renal function (Thompson et al., J Urol 182:41–45, 2009). Non-surgical thermal ablative tech作者: ATP861 時(shí)間: 2025-3-25 06:15
The Role of Ablative Therapies in Renal Cancer,ablative therapies compared to partial nephrectomy (PN), however, as no randomized control trial exists, there is often selection bias. Cancer specific survival (CSS) and disease free survival (DFS) have been comparable for thermal ablative techniques. Local recurrence rates are higher for thermal a作者: Needlework 時(shí)間: 2025-3-25 07:36 作者: Abutment 時(shí)間: 2025-3-25 13:01 作者: 爭論 時(shí)間: 2025-3-25 18:58 作者: 土產(chǎn) 時(shí)間: 2025-3-25 20:57
Lymph Node Dissection in Renal Cancer and Upper Tract Urothelial Cancer,y advanced disease and may be of therapeutic benefit in some patients. Several retrospective studies support the hypothesis that LND may be beneficial in high risk patients such as clinical T3-T4, high grade, those with sarcomatoid features or coagulative tumour necrosis. A subset of patients with p作者: Alpha-Cells 時(shí)間: 2025-3-26 02:58 作者: 使混合 時(shí)間: 2025-3-26 05:23
Ryan L. Steinberg,Brett A. Johnson,Jeffrey A. Cadeddu,Abhay Rane作者: Aspiration 時(shí)間: 2025-3-26 10:38
Eduard Roussel,Mattias Willem van Hattem,Maarten Albersen,Steven Joniau,Hendrik Van Poppel作者: Jingoism 時(shí)間: 2025-3-26 13:27 作者: 同步左右 時(shí)間: 2025-3-26 19:33 作者: 打火石 時(shí)間: 2025-3-27 00:02
Christopher Anderson,Mehran Afsharof nonfatal myocardial infarction are selected as primary response variables. The analysis of such event rates in two groups could employ the chi-square statistic or the equivalent normal statistic for the comparison of two proportions. However, when the length of observation is different for each p作者: cardiac-arrest 時(shí)間: 2025-3-27 04:33 作者: 兵團(tuán) 時(shí)間: 2025-3-27 08:04
Scott T. C. Shepherd,Samra Turajlicof nonfatal myocardial infarction are selected as primary response variables. The analysis of such event rates in two groups could employ the chi-square statistic or the equivalent normal statistic for the comparison of two proportions. However, when the length of observation is different for each p作者: Lipoprotein(A) 時(shí)間: 2025-3-27 12:12 作者: 確定方向 時(shí)間: 2025-3-27 15:25 作者: defibrillator 時(shí)間: 2025-3-27 21:38 作者: 演講 時(shí)間: 2025-3-27 23:04
V. Khoo,D. Lim-Joonthe oocyte (vitellogenesis) (this is the most common mode in nonmammalian species); (2) the direct provision of nutrients to the developing young through the intermediary of the uterine wall by either secretory activity (histotroph) or (3) a direct maternal connection (placentation) (Table I). In eg作者: GOAD 時(shí)間: 2025-3-28 03:02 作者: 無節(jié)奏 時(shí)間: 2025-3-28 07:31
e use of hybrid, real and virtual simulation techniques.Feat.Renal Cancer: Current Status and Innovations .provides a useful guide to the fundamental basics and latest diagnostic and treatment techniques for Renal Cancer. It features clearly structured and easy-to-understand chapters enabling the re作者: 鈍劍 時(shí)間: 2025-3-28 11:11 作者: engrossed 時(shí)間: 2025-3-28 14:49 作者: Inexorable 時(shí)間: 2025-3-28 21:48
Book 2022nal Cancer. It features clearly structured and easy-to-understand chapters enabling the reader to develop a thorough understanding of screening, surveillance, diagnostics, pathology, robotic and open surgical approaches, ablation, medical treatment, psychology, and future innovations...?The book pro作者: 環(huán)形 時(shí)間: 2025-3-29 00:21 作者: 極少 時(shí)間: 2025-3-29 04:58 作者: Adj異類的 時(shí)間: 2025-3-29 09:00
Hereditary Renal Cancer Predisposition Syndromes,al cancer syndromes account for 4–6% of RCC diagnoses. Pathogenic germline variants in at least 12 genes—. & .—are associated with distinct clinical syndromes each with varying incidence of RCC and extrarenal manifestations. Inheritance is typically in an autosomal dominant manner, although penetran作者: 永久 時(shí)間: 2025-3-29 12:49 作者: Mutter 時(shí)間: 2025-3-29 17:33 作者: 扔掉掐死你 時(shí)間: 2025-3-29 21:10
Biomarkers, Early Detection and Biomarker Based Treatment of Renal Cancer,d late, the survival, despite treatment, remains poor..A major challenge in managing renal cancer stems from the heterogenous nature of the disease. There is a diverse range in terms of tumour phenotypes and histological profiles. Furthermore, a renal tumour can range from the benign end of the spec作者: Fortuitous 時(shí)間: 2025-3-30 03:47
The Role of Biopsy in RCC,r renal lesions identified on imaging studies. Historically RMB has been underutilised by clinicians due to concerns regarding safety and accuracy, however numerous studies in the contemporary era have demonstrated RMB to be an effective technique for obtaining histological specimens to help clinici作者: 頌揚(yáng)本人 時(shí)間: 2025-3-30 07:38 作者: Hay-Fever 時(shí)間: 2025-3-30 08:45
The Role of Ablative Therapies in Renal Cancer,ble oncological outcomes to traditional surgery. Percutaneous ablation techniques have been gaining popularity as they are less invasive, have fewer complications and cost less. Ablative therapies currently being used include cryoablation (CRA), radiofrequency ablation (RFA), microwave ablation (MWA作者: 斷斷續(xù)續(xù) 時(shí)間: 2025-3-30 15:32
Radical Nephrectomy for Renal Cell Carcinoma: Non-robotic Minimally Invasive Approaches,renal fat and Gerota’s fascia) in the 1960s given the demonstrated improvement in oncologic outcomes. Since the initial report in 1991, the laparoscopic approach to radical nephrectomy has been widely adopted for complete kidney removal given its improved post-operative recovery as compared to open 作者: Vulvodynia 時(shí)間: 2025-3-30 18:52
Radical Nephrectomy: Role of Robotic Assisted Approach,ours which are not amenable to partial nephrectomy, to more complex larger tumours which would previously be considered for open surgery. Robotics offers finer dexterity and magnification than a purely laparoscopic approach, as we have seen with robotic partial nephrectomy. While often considered mo作者: 高貴領(lǐng)導(dǎo) 時(shí)間: 2025-3-30 23:11 作者: progestogen 時(shí)間: 2025-3-31 04:53 作者: BADGE 時(shí)間: 2025-3-31 07:56
Transperitoneal Robotic Partial Nephrectomy,advantages of minimally invasive surgery (faster postoperative recovery, reduced blood loss, and postoperative pain) along with a wider range of movement, three-dimensional (3D) and magnified vision, and the camera controlled by the primary surgeon. The application of preoperative scoring systems im作者: 哎呦 時(shí)間: 2025-3-31 11:17
Lymph Node Dissection in Renal Cancer and Upper Tract Urothelial Cancer,ailable evidence is mainly retrospective, often of poor quality, and predates the era of effective systemic therapy. The lymphatic drainage from the kidneys is highly variable and LND templates are not standardised or defined. Lymph node involvement at the time of nephrectomy is usually associated w作者: 織布機(jī) 時(shí)間: 2025-3-31 14:38 作者: Metamorphosis 時(shí)間: 2025-3-31 18:40 作者: 鄙視 時(shí)間: 2025-3-31 22:35
Metastatic Tumours: Cytoreductive Nephrectomy,tatic renal cell carcinoma. The evidence surrounding this controversial treatment is reviewed and other indications for nephrectomy are discussed. We discuss the complex issues surrounding patient selection and how this may be improved in the future to choose the appropriate case for CRN.作者: Ferritin 時(shí)間: 2025-4-1 02:54
Pathological Classification and Biomarkers,tline the key features of the different sub-types of RCC, including those associated with hereditary syndromes. We describe the characteristics of 2 ‘emerging’ entities that may be formally recognised in the future and briefly discuss the role of novel biomarkers in RCC.作者: 潛伏期 時(shí)間: 2025-4-1 06:23 作者: 完全 時(shí)間: 2025-4-1 13:24 作者: IDEAS 時(shí)間: 2025-4-1 17:58
reatment, psychology, and future innovations...?The book provides a valuable resource for the full spectrum of clinicians involved in the multidisciplinary management of Renal Cancer..978-3-030-84758-6978-3-030-84756-2作者: 完全 時(shí)間: 2025-4-1 20:06
